Funded Tech Companies

Carmine Therapeutics

Carmine Therapeutics is a biopharmaceutical tech venture, located in Cambridge. Investment was provided by Cystic Fibrosis Foundation, EVX Ventures and Huagai Capital.

Company Overview

Contact Information

Company Background Information

Overview

Our vision is to make genetic medicines broadly accessible to address the unmet medical needs of patients. Carmine Therapeutics is an EVX Ventures company that is headquartered in Cambridge, Massachusetts. We are pioneering powerful new genetic medicines that are based on red blood cell extracellular vesicles (RBCEVs). Our proprietary Red Cell EV Gene Therapy (REGENT®) platform generates a pipeline of next-generation disease-modifying gene therapies for a broad spectrum of diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/13/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Don Haut

        

Vice President

Ozan Alkan

        

Vice President

John Robblee

        

Vice President

Qin Yu

        

Company Investors

• Cystic Fibrosis Foundation
• EVX Ventures
• Huagai Capital
• Simcere Pharmaceutical Group

Browse more funded tech companies:

Carmera | Carmoola

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary